TNF and diabetes mellitus: Moreover, the level of TNF-α were significantly reduced in STZ induced diabetes treated groups with valsartan (85.74 ± 3.85 pg/ml; P < 0.01 vs. DC group) and LCZ696 (77.52 ± 5.5 pg/ml; P < 0.001 vs. DC group).